Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Hisse Senetlerindeki Sıralama #25542
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Hisse Fiyatı
$22.27
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$46.11M
Değişim (1 gün)
-1.50%
Değişim (1 yıl)
-54.15%
Ülke
GB
Ticaret Hikma Pharmaceuticals PLC (HIK)

Kategori

Healthcare
Hikma Pharmaceuticals PLC (HIK) için P/B oranı
2026 itibarıyla P/B oranı TTM: 0
Hikma Pharmaceuticals PLC şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 0'dir. 2026 yılının sonunda şirketin P/B oranı 0 idi.
Hikma Pharmaceuticals PLC için P/B oranı geçmişi 2026 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için P/B oranı